Foda A, Kellner E, Gunawardana A, Gao X, Janz M, Kufner A
Clin Neuroradiol. 2021; 32(1):239-248.
PMID: 34940899
PMC: 8894153.
DOI: 10.1007/s00062-021-01129-8.
Kufner A, Khalil A, Galinovic I, Kellner E, Mekle R, Rackoll T
J Cereb Blood Flow Metab. 2021; 41(10):2617-2627.
PMID: 33866849
PMC: 8504415.
DOI: 10.1177/0271678X211010071.
Choi H, Ryu C, Kim S, Rhee H, Jahng G
Front Neurol. 2020; 11:545450.
PMID: 33192974
PMC: 7658467.
DOI: 10.3389/fneur.2020.545450.
Yamamoto A, Takaki K, Morikawa S, Murata K, Ito R
Magn Reson Med Sci. 2020; 20(3):264-271.
PMID: 32830172
PMC: 8424023.
DOI: 10.2463/mrms.mp.2019-0134.
He Y, Wang M, Yu X
J Cereb Blood Flow Metab. 2019; 40(10):2098-2114.
PMID: 31696765
PMC: 7786852.
DOI: 10.1177/0271678X19886240.
MRI Imaging of the Hemodynamic Vasculature of Neuroblastoma Predicts Response to Antiangiogenic Treatment.
Zormpas-Petridis K, Jerome N, Blackledge M, Carceller F, Poon E, Clarke M
Cancer Res. 2019; 79(11):2978-2991.
PMID: 30877107
PMC: 6558276.
DOI: 10.1158/0008-5472.CAN-18-3412.
Validation of vessel size imaging (VSI) in high-grade human gliomas using magnetic resonance imaging, image-guided biopsies, and quantitative immunohistochemistry.
Chakhoyan A, Yao J, Leu K, Pope W, Salamon N, Yong W
Sci Rep. 2019; 9(1):2846.
PMID: 30808879
PMC: 6391482.
DOI: 10.1038/s41598-018-37564-w.
The Continuing Evolution of Molecular Functional Imaging in Clinical Oncology: The Road to Precision Medicine and Radiogenomics (Part II).
Vaidya T, Agrawal A, Mahajan S, Thakur M, Mahajan A
Mol Diagn Ther. 2018; 23(1):27-51.
PMID: 30387041
DOI: 10.1007/s40291-018-0367-3.
Experimental MRI Monitoring of Renal Blood Volume Fraction Variations to Renal Magnetic Resonance Oximetry.
Pohlmann A, Cantow K, Huelnhagen T, Grosenick D, Periquito J, Boehmert L
Tomography. 2018; 3(4):188-200.
PMID: 30042981
PMC: 6024389.
DOI: 10.18383/j.tom.2017.00012.
Imaging vascular and hemodynamic features of the brain using dynamic susceptibility contrast and dynamic contrast enhanced MRI.
Quarles C, Bell L, Stokes A
Neuroimage. 2018; 187:32-55.
PMID: 29729392
PMC: 6538021.
DOI: 10.1016/j.neuroimage.2018.04.069.
Dynamic Biomarkers of Response to Antiangiogenic Therapies in Colorectal Cancer: A Review.
Rodriguez-Pascual J, Cubillo A
Curr Pharmacogenomics Person Med. 2018; 15(2):81-85.
PMID: 29657584
PMC: 5872368.
DOI: 10.2174/1875692115666170815161754.
Vessel radius mapping in an extended model of transverse relaxation.
Buschle L, Ziener C, Zhang K, Sturm V, Kampf T, Hahn A
MAGMA. 2018; 31(4):531-551.
PMID: 29478154
DOI: 10.1007/s10334-018-0677-9.
Patient-derived organoids model treatment response of metastatic gastrointestinal cancers.
Vlachogiannis G, Hedayat S, Vatsiou A, Jamin Y, Fernandez-Mateos J, Khan K
Science. 2018; 359(6378):920-926.
PMID: 29472484
PMC: 6112415.
DOI: 10.1126/science.aao2774.
Evaluation of the Response of Intracranial Xenografts to VEGF Signaling Inhibition Using Multiparametric MRI.
Boult J, Box G, Vinci M, Perryman L, Eccles S, Jones C
Neoplasia. 2017; 19(9):684-694.
PMID: 28780387
PMC: 5547238.
DOI: 10.1016/j.neo.2017.05.007.
Monitoring the Vascular Response and Resistance to Sunitinib in Renal Cell Carcinoma with Susceptibility Contrast MRI.
Robinson S, Boult J, Vasudev N, Reynolds A
Cancer Res. 2017; 77(15):4127-4134.
PMID: 28566330
PMC: 6175052.
DOI: 10.1158/0008-5472.CAN-17-0248.
Investigating intracranial tumour growth patterns with multiparametric MRI incorporating Gd-DTPA and USPIO-enhanced imaging.
Boult J, Borri M, Jury A, Popov S, Box G, Perryman L
NMR Biomed. 2016; 29(11):1608-1617.
PMID: 27671990
PMC: 5082561.
DOI: 10.1002/nbm.3594.
Translational MR Neuroimaging of Stroke and Recovery.
Mandeville E, Ayata C, Zheng Y, Mandeville J
Transl Stroke Res. 2016; 8(1):22-32.
PMID: 27578048
PMC: 5243530.
DOI: 10.1007/s12975-016-0497-z.
Markers of Response to Antiangiogenic Therapies in Colorectal Cancer: Where Are We Now and What Should Be Next?.
Cidon E, Alonso P, Masters B
Clin Med Insights Oncol. 2016; 10(Suppl 1):41-55.
PMID: 27147901
PMC: 4849423.
DOI: 10.4137/CMO.S34542.
Clinical translation of ferumoxytol-based vessel size imaging (VSI): Feasibility in a phase I oncology clinical trial population.
Fredrickson J, Serkova N, Wyatt S, Carano R, Pirzkall A, Rhee I
Magn Reson Med. 2016; 77(2):814-825.
PMID: 26918893
PMC: 5677523.
DOI: 10.1002/mrm.26167.
Comparison of the Effect of Vessel Size Imaging and Cerebral Blood Volume Derived from Perfusion MR Imaging on Glioma Grading.
Kang H, Xiao H, Chen J, Tan Y, Chen X, Xie T
AJNR Am J Neuroradiol. 2015; 37(1):51-7.
PMID: 26381565
PMC: 7960212.
DOI: 10.3174/ajnr.A4477.